Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17-demethoxygeldanamycin in pediatric patients with recurrent or refractory solid tumors: a pediatric oncology experimental therapeutics investigators consortium study.

Bagatell R, Gore L, Egorin MJ, Ho R, Heller G, Boucher N, Zuhowski EG, Whitlock JA, Hunger SP, Narendran A, Katzenstein HM, Arceci RJ, Boklan J, Herzog CE, Whitesell L, Ivy SP, Trippett TM
Clin Cancer Res. 2007 13 (6): 1783-8

PMID: 17363533 · DOI:10.1158/1078-0432.CCR-06-1892

MeSH Terms (16)

Adolescent Adult Antineoplastic Agents Benzoquinones Biomarkers, Tumor Child Child, Preschool Female Humans Lactams, Macrocyclic Male Maximum Tolerated Dose Neoplasms Pediatrics Recurrence Treatment Failure

Connections (2)

This publication is referenced by other Labnodes entities: